Submission for OMB Review; 30-Day Comment Request; ABCD Study® Data Use Certification (National Institute on Drug Abuse), 63968-63969 [2023-20075]
Download as PDF
<![CDATA[
63968
Federal Register / Vol. 88, No. 179 / Monday, September 18, 2023 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Submission for OMB Review; 30-Day
Comment Request; ABCD Study® Data
Use Certification (National Institute on
Drug Abuse)
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Rational Systematic
Characterization and Selection of Adjuvants
for HIV Vaccine Candidates (R–CASA).
Date: October 10, 2023.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Rockville, MD
20892 (Virtual Meeting).
Contact Person: Stephen Anthony Gallo,
Ph.D., Scientific Review Officer, Scientific
Review Program, National Institute of Allergy
and Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, MSC–9823,
Rockville, MD 20852, (240) 669–2858,
steve.gallo@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: September 12, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–20105 Filed 9–15–23; 8:45 am]
BILLING CODE 4140–01–P
AGENCY:
were received. The purpose of this
notice is to allow an additional 30 days
for public comment. The National
Institute on Drug Abuse (NIDA),
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection Title: ABCD
Study® Data Use Certification, 0925–
NEW, exp., date XX/XX/XXXX,
National Institute on Drug Abuse
(NIDA), National Institutes of Health
(NIH).
Need and Use of Information
Collection: The purpose of this proposal
is to inform data requestors about terms
and conditions for using data generated
by the Adolescent Brain Cognitive
Development(SM) (ABCD) Study and to
obtain signed agreements from
requestors and their institutional
officials attesting to their commitment
to abide by the data use terms and
conditions. These include using data for
research purposes; adhering to human
subjects research requirements; not
distributing the data to non-authorized
users; minimizing risk of participant
identifiability; using data ethically and
responsibly; and keeping the data
secure. Users must include a brief
description of their research project and
submit their signed data use agreements
to the data repository to gain access to
the ABCD Study® data. Users who plan
to conduct research studies specifically
on American Indian/Alaska Native (AI/
AN) populations must submit an
additional signed data use certification.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
2,000.
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30 days of the date of this
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Dr. Elizabeth A.
Hoffman, Senior Scientific Program
Manager, Division of Extramural
Research, National Institute on Drug
Abuse, C/O NIH Mail Center/Dock 11,
3WFN Room 09C75 MSC 6021, 16071
Industrial Drive, Gaithersburg, MD
20877 (20892 for USPS), or call non-tollfree number (301) 594–2265 or Email
your request, including your address to:
elizabeth.hoffman@nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on April 26, 2023, page 25411
(88 FR 25411) and allowed 60 days for
public comment. No public comments
SUMMARY:
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
lotter on DSK11XQN23PROD with NOTICES1
Type of respondent
Number of
responses per
respondent
Average time
per response
(in hours)
Total annual
burden hour
Individuals (standard DUC form) .....................................................................
Individuals (additional AI/AN DUC form when applicable) ..............................
1,800
200
1
1
1
1
1,800
200
Total ..........................................................................................................
........................
2,000
........................
2,000
VerDate Sep<11>2014
18:29 Sep 15, 2023
Jkt 259001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
E:\FR\FM\18SEN1.SGM
18SEN1
Federal Register / Vol. 88, No. 179 / Monday, September 18, 2023 / Notices
Lanette A. Palmquist,
Project Clearance Liaison, National Institute
on Drug Abuse, National Institutes of Health.
[FR Doc. 2023–20075 Filed 9–15–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meetings
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; NIMHD Mentored
Career and Research Development Awards
(Ks).
Date: October 26–27, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIMHD, DEM II, Suite 800, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Deborah Ismond, Ph.D.,
Scientific Review Officer, Office of
Extramural Research Administration,
National Institute on Minority Health and
Health Disparities, National Institutes of
Health, 6707 Democracy Blvd., Suite 800,
Bethesda, MD 20892, (301) 594–2704,
ismonddr@mail.nih.gov.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; NIMHD Centers of
Excellence in Investigator Development and
Community Engagement (P50—Clinical Trial
Optional).
Date: November 1–2, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIMHD, DEM II, Suite 800, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Maryline Laude-Sharp,
Ph.D., Scientific Review Officer, Office of
Extramural Research Administration,
National Institute on Minority Health and
Health Disparities, National Institutes of
VerDate Sep<11>2014
18:29 Sep 15, 2023
Jkt 259001
Health, 6707 Democracy Boulevard, Suite
800, Bethesda, MD 20892, 301–451–9536,
mlaudesharp@mail.nih.gov.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; Community Level
Interventions to Improve Minority Health
and Reduce Health Disparities.
Date: November 9, 2023.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIMHD, DEM II, Suite 800, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Ivan K. Navarro, Ph.D.,
Scientific Review Officer, Office of
Extramural Research Administration
National Institute on Minority Health and
Health Disparities, National Institutes of
Health, 6707 Democracy Blvd., Suite 800,
Bethesda, MD 20892, 301–827–2061,
ivan.navarro@nih.gov.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; NIMHD Support for
Conferences and Scientific Meetings (R13).
Date: November 14, 2023.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIMHD, DEM II, Suite 800, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Xinli Nan, M.D., Ph.D.,
Scientific Review Officer, Office of
Extramural Research Activities National
Institute on Minority Health and Health
Disparities, National Institutes of Health,
6707 Democracy Boulevard, Suite 800,
Bethesda, MD 20892, (301) 594–7784,
Xinli.Nan@nih.gov.
Dated: September 12, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
63969
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel;
Conflicting Application Review of NRRC
Meeting.
Date: October 10, 2023.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Nursing
Research, 6701 Democracy Boulevard,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joshua Wolff, Ph.D.,
Scientific Review Officer/Social & Behavioral
Scientist, Scientific Review Branch, National
Institute of Nursing Research, 6701
Democracy Boulevard, Bethesda, MD 20892,
301–793–5758, Joshua.wolff@nih.gov.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel;
NINR T32 Training Grant Applications
Review Meeting.
Date: October 26, 2023.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Nursing
Research, 6701 Democracy Boulevard,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nisan Bhattacharyya,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute of Nursing
Research, 6701 Democracy Boulevard, Room
720, Bethesda, MD 20892, 301–435–6979,
nisan.bhattacharyya@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: September 12, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–20061 Filed 9–15–23; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2023–20058 Filed 9–15–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
National Institute of Nursing Research;
Notice of Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
E:\FR\FM\18SEN1.SGM
18SEN1
]]>Agencies
[Federal Register Volume 88, Number 179 (Monday, September 18, 2023)]
[Notices]
[Pages 63968-63969]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20075]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request; ABCD
Study[supreg] Data Use Certification (National Institute on Drug Abuse)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30 days of the date of
this publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Dr. Elizabeth A. Hoffman, Senior Scientific
Program Manager, Division of Extramural Research, National Institute on
Drug Abuse, C/O NIH Mail Center/Dock 11, 3WFN Room 09C75 MSC 6021,
16071 Industrial Drive, Gaithersburg, MD 20877 (20892 for USPS), or
call non-toll-free number (301) 594-2265 or Email your request,
including your address to: [email protected].
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on April 26, 2023, page
25411 (88 FR 25411) and allowed 60 days for public comment. No public
comments were received. The purpose of this notice is to allow an
additional 30 days for public comment. The National Institute on Drug
Abuse (NIDA), National Institutes of Health, may not conduct or
sponsor, and the respondent is not required to respond to, an
information collection that has been extended, revised, or implemented
on or after October 1, 1995, unless it displays a currently valid OMB
control number.
In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, the National Institutes of Health (NIH) has submitted to
the Office of Management and Budget (OMB) a request for review and
approval of the information collection listed below.
Proposed Collection Title: ABCD Study[supreg] Data Use
Certification, 0925-NEW, exp., date XX/XX/XXXX, National Institute on
Drug Abuse (NIDA), National Institutes of Health (NIH).
Need and Use of Information Collection: The purpose of this
proposal is to inform data requestors about terms and conditions for
using data generated by the Adolescent Brain Cognitive
Development\(SM)\ (ABCD) Study and to obtain signed agreements from
requestors and their institutional officials attesting to their
commitment to abide by the data use terms and conditions. These include
using data for research purposes; adhering to human subjects research
requirements; not distributing the data to non-authorized users;
minimizing risk of participant identifiability; using data ethically
and responsibly; and keeping the data secure. Users must include a
brief description of their research project and submit their signed
data use agreements to the data repository to gain access to the ABCD
Study[supreg] data. Users who plan to conduct research studies
specifically on American Indian/Alaska Native (AI/AN) populations must
submit an additional signed data use certification.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 2,000.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Type of respondent Number of responses per per response Total annual
respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
Individuals (standard DUC form)................. 1,800 1 1 1,800
Individuals (additional AI/AN DUC form when 200 1 1 200
applicable)....................................
---------------------------------------------------------------
Total....................................... .............. 2,000 .............. 2,000
----------------------------------------------------------------------------------------------------------------
[[Page 63969]]
Lanette A. Palmquist,
Project Clearance Liaison, National Institute on Drug Abuse, National
Institutes of Health.
[FR Doc. 2023-20075 Filed 9-15-23; 8:45 am]
BILLING CODE 4140-01-P
